Resource data sheet
Prev.
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

CDCA7 px330

Expression vector of guide RNA for targeting human CDCA7 exon 7.

Catalog number RDB17380
Resource name CDCA7 px330
Alternative name CDCA7 exon7 pX330-U6-Chimeric_BB-CBh-hSpCas9
Clone info. Expression vector of guide RNA for targeting human cell division cycle associated 7 (CDCA7) exon 7 (5'-TCAGAAGACTATTGATACCA-3') and human codon-optimized SpCas9.
Vector backbone pX330-U6-Chimeric_BB-CBh-hSpCas9 (plasmid)
Size of vector backbone 8.5 kb
Selectable markers Amp^r (E. coli)
Gene/insert name human CDCA7 dsOligo
Depositor|Developer Unoki, Motoko |
Other clones in our bank

External Database
human CDCA7

          Reference sequence
            
           

          Distribution information

          Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
          Terms and conditions for distribution In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR (Unoki, M et al. J. Clin. Invest. 129 (1), 78-92, 2019) and an acknowledgment to the DEPOSITOR are requested.
          Ordering
          Order form [Credit Card Payment]  [Bank Transfer Payment]
          Exclusive MTA (For the DNA materials containing CRISPR/Cas9 technologies and for not-for-profit academic purpose) [Word]
          Please visit Information of Request for Distribution.[link] 
          Remarks
          The BIOLOGICAL RESOURCE contains CRISPR/Cas9 technologies and is not provided to for-profit organization or for for-profit research by non-profit organizations.
          提供案内 (日本国内) [open/close]

          提供条件 利用者は、研究成果の公表にあたって寄託者の指定する文献 (Unoki, M et al. J. Clin. Invest. 129 (1), 78-92, 2019) を引用し、謝辞の表明を必要とする。
          提供依頼
          提供依頼書 [Word]
          専用MTA(CRISPR/Cas9内包遺伝子材料専用 非営利学術目的)をお使いください [Word]
          手続きの概要は、「提供申込みについて[link]」をご覧ください。
          備考
          本件リソースはCRISPR/Cas9 technologyを用いたゲノム編集バイオリソースです。営利機関および非営利機関による営利目的研究には提供いたしません。

          Catalog # Resource name Shipping form Fee (non-profit org.)
          RDB17380 CDCA7 px330 DNA solution

          Please review the QC test results indicated by check icon below as well as clone information before placing your order.

          How to cite this biological resource

          Materials & Methods section:

          The CDCA7 px330 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB17380).

          Reference section:

          Unoki, M., Funabiki, H., Velasco, G., Francastel, C., Sasaki, H., CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome. J. Clin. Invest. 129 (1): 78-92 (2019). PMID 30307408. [link to RRC of NBRP]

          Further references such as user reports and related articles (go to bottom)


          Tips

          Featured content


          QC test results

          RIKEN BRC has sequenced portions of this material for quality test.
          Please review the QC test results indicated by check icon as well as clone information before placing your order.

          Test sheet RDB17380_A9Fhp1-1.pdf check

          Nucleotide sequence of a portion of this resource (if available).

          Primer: SV40pA3'element reverse (Pr0108)
          Region: U6 pro, gRNA (CDCA7) gRNA scaffold, CBh pro 5'
          Sequence file: RDB17380_A9Fha.seq check
          >D06399A7_A9Fh_2_SV40pA3'element reverse_C03_09_ABI24.ab1
              1 NNNNNNNNNN NNNNNNNNNN NNNNNNNNNG CNNGCAACGC GGCCTTTTTA CGGTTCCTGG
             61 CCTTTTGCTG GCCTTTTGCT CACATGTGAG GGCCTATTTC CCATGATTCC TTCATATTTG
            121 CATATACGAT ACAAGGCTGT TAGAGAGATA ATTGGAATTA ATTTGACTGT AAACACAAAG
            181 ATATTAGTAC AAAATACGTG ACGTAGAAAG TAATAATTTC TTGGGTAGTT TGCAGTTTTA
            241 AAATTATGTT TTAAAATGGA CTATCATATG CTTACCGTAA CTTGAAAGTA TTTCGATTTC
            301 TTGGCTTTAT ATATCTTGTG GAAAGGACGA AACACCGTGG TATCAATAGT CTTCTGAGTT
            361 TTAGAGCTAG AAATAGCAAG TTAAAATAAG GCTAGTCCGT TATCAACTTG AAAAAGTGGC
            421 ACCGAGTCGG TGCTTTTTTG TTTTAGAGCT AGAAATAGCA AGTTAAAATA AGGCTAGTCC
            481 GTTTTTAGCG CGTGCGCCAA TTCTGCAGAC AAATGGCTCT AGAGGTACCC GTTACATAAC
            541 TTACGGTAAA TGGCCCGCCT GGCTGACCGC CCAACGACCC CCGCCCATTG ACGTCAATAG
            601 TAACGCCAAT AGGGACTTTC CATTGACGTC AATGGGTGGA GTATTTACGG TAAACTGCCC
            661 ACTTGGCAGT ACATCAAGTG TATCATATGC CAAGTACGCC CCCTATTGAC GTCAATGACG
            721 GTAAATGGCC CGCCTGGCAT TGTGCCCAGT ACATGACCTT ATGGGACTTT CCTACTTGGC
            781 AGTACATCTA CGTATTAGTC ATCGCTATTA CCATGGTCGA NGTGAGCCCC ACGTTCTGCT
            841 TCACTCTCCC CATCTCCCCC CCCCNNCCCA CCCCCAATTT TGTATTTATT TATTTTTTTA
          901 ATTATTTTGT GCAGCGATGG GGGCGGGGGG GGGGGGGGGG GGNNNNNNNN NN
          //
          Primer: Cas9-N_R1 (Pr0650)
          Region: Cas9 5', SV40 NLS, 3xFLAG, CBh pro 3'
          Sequence file: RDB17380_A9Fhb.seq check
          >D06399A7_A9Fh_2_Cas9-N_R1_C02_08_ABI24.ab1
              1 NNNNNNNNNN NNNGNNNNGN NNNTTGNNNT CGTCGGTGNN CACGGCCCAG CCCACAGAGT
             61 TGGTGCCGAT GTCCAGGCCG ATGCTGTACT TCTTGTCGGC TGCTGGGACT CCGTGGATAC
            121 CGACCTTCCG CTTCTTCTTT GGGGCCATCT TATCGTCATC GTCTTTGTAA TCAATATCAT
            181 GATCCTTGTA GTCTCCGTCG TGGTCCTTAT AGTCCATGGT GGCACCGGTC CAACCTGAAA
            241 AAAAGTGATT TCAGGCAGGT GCTCCAGGTA ATTAAACATT AATACCCCAC CAACCAACCA
            301 TCCCTTAAAC CCTTACCTCT TGCTCAGCTA ATTACAGCCC GGAGGAGAAG GGCCGTCCCG
          361 CCCGCTCACC TGTGGGAGTA ACGCGGTCAG TCAGAGCCGG GGCGGGCGGC GCGAGGNN
          //
          Primer: BGH_rev2 (Pr0606)
          Region: bGH p(A), nucleoplasmin NLS, Cas9 3'
          Sequence file: RDB17380_A9Fhc.seq check
          >D06399A7_A9Fh_2_BGH_rev2_B02_02_ABI08.ab1
              1 NNNNNNNNNN NNNNNNNNNN NNNNNNNGNN GGNNNNNNNA CAGATGGCTG GCAACTAGAA
             61 GGCACAGTCG AGGCTGATCA GCGAGCTCTA GGAATTCTTA CTTTTTCTTT TTTGCCTGGC
            121 CGGCCTTTTT CGTGGCCGCC GGCCTTTTGT CGCCTCCCAG CTGAGACAGG TCGATCCGTG
            181 TCTCGTACAG GCCGGTGATG CTCTGGTGGA TCAGGGTGGC GTCCAGCACC TCTTTGGTGC
            241 TGGTGTACCT CTTCCGGTCG ATGGTGGTGT CAAAGTACTT GAAGGCGGCA GGGGCTCCCA
            301 GATTGGTCAG GGTAAACAGG TGGATGATAT TCTCGGCCTG CTCTCTGATG GGCTTATCCC
            361 GGTGCTTGTT GTAGGCGGAC AGCACTTTGT CCAGATTAGC GTCGGCCAGG ATCACTCTCT
            421 TGGAGAACTC GCTGATCTGC TCGATGATCT CGTCCAGGTA GTGCTTGTGC TGTTCCACAA
            481 ACAGCTGTTT CTGCTCATTA TCCTCGGGGG AGCCCTTCAG CTTCTCATAG TGGCTGGCCA
            541 GGTACAGGAA GTTCACATAT TTGGAGGGCA GGGCCAGTTC GTTTCCCTTC TGCAGTTCGC
            601 CGGCAGAGGC CAGCATTCTC TTCCGGCCGT TTTCCAGCTC GAACAGGGAG TACTTAGGCA
            661 GCTTGATGAT CAGGTCCTTT TTCACTTCTT TGTAGCCCTT GGCTTCCAGA AAGTCGATGG
            721 GANTCTTCTC GAAGCTGCTT CTTTCCATGA TGGTGATCCC CAGCAGCTCT TTCACACTCT
            781 TCAGTTTCTT GGACTTGCCC TTTTCCACTT TGGCCACCAC CAGCACAGAA TANGCCACGG
            841 NGGGGCTGTC GAANCCGCCG NACTTCTTAN GGTCCCAGTC CTTCTTTCTG GCNANCAGCN
            901 TATCGCTGTN CCNCNNNGGC ANGATAGANN CNTTNNCTNA AGCCNNNNGN NNGCNNCNNN
          961 GGNCNTTTTT CNCNANNNTN NNNNTNNNGG NNNNNNNNNN
          //

          Please visit Sequencing and PCR primers for primer information.


          References

          Original, user report and related articles

          original Unoki, M., CDCA7 and HELLS mutations undermine nonhomologous end joining in centromeric instability syndrome. J. Clin. Invest. 129 (1): 78-92 (2019). PMID 30307408. [link to RRC of NBRP]

          2023.08.17

          GNP_filter3_RDBDEP_html_230702.pl